The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects

Andrey Zyubin; Anastasiya Lavrova; Maksim Demin; Alina Pankina; Svetlana Babak

doi:10.1016/j.dib.2017.03.016

Data in Brief (Apr 2017)

The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects

Andrey Zyubin,
Anastasiya Lavrova,
Maksim Demin,
Alina Pankina,
Svetlana Babak

Affiliations

Andrey Zyubin: Immanuel Kant Baltic Federal University, A. Nevskogo St. 14, Kaliningrad 236016, Russia
Anastasiya Lavrova: Immanuel Kant Baltic Federal University, A. Nevskogo St. 14, Kaliningrad 236016, Russia
Maksim Demin: Immanuel Kant Baltic Federal University, A. Nevskogo St. 14, Kaliningrad 236016, Russia
Alina Pankina: Immanuel Kant Baltic Federal University, A. Nevskogo St. 14, Kaliningrad 236016, Russia
Svetlana Babak: Immanuel Kant Baltic Federal University, A. Nevskogo St. 14, Kaliningrad 236016, Russia

DOI: https://doi.org/10.1016/j.dib.2017.03.016
Journal volume & issue: Vol. 11, no. C
pp. 522 – 526

Abstract

Read online

The present work contains data obtained during the analysis of blood samples obtained from patients (number: 102, age: 0–2 years old) with confirmed acute lymphoblastic leukemia diagnosis. Among these total number, 48 patients who received a chemotherapy including 9 patients with side-effects were chosen. Final data include a table of protein masses (biomarkers of pathological processes at the chemotherapy) obtained by the MALDI-TOF spectroscopy from blood of 9 chosen patients (0–2 years old).

Published in Data in Brief

ISSN: 2352-3409 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General): Computer applications to medicine. Medical informatics; Science: Science (General)
Website: http://www.journals.elsevier.com/data-in-brief/

About the journal

Abstract

Keywords